The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis

Pauline L. M. Verhaegh, Wenke Moris, Ger H. Koek, Cees Th. B. M. van Deursen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)

Abstract

ObjectivePhenotypes of the HFE-related haemochromatosis vary considerably, making it hard to predict the course of iron accumulation. The aim of this retrospective study was to determine if the Iron Avidity Index (IAI) is a good phenotypic predictor of the number of phlebotomies needed per year during maintenance treatment (NPDMT) in patients with homozygous p.C282Y hereditary haemochromatosis (HH). MethodsPatients with HH homozygous for p.C282Y, on maintenance treatment for at least 1 year were included. The IAI (ferritin level at diagnosis/age at diagnosis) was calculated. ResultsNinety-five patients were included in the analysis. Linear regression analysis showed the confounding effect of sex on the relationship between IAI and NPDMT. A modified IAI, adjusted for sex, was calculated. As proton pump inhibitor (PPI) use was independently associated with NPDMT, the group was split in PPI- and non-PPI-users. A positive correlation between the modified IAI and the NPDMT was shown in both groups (PPI r = 0.367, P = 0.023; non-PPI r = 0.453, P <0.001). An ROC was computed to measure the accuracy of the modified IAI to predict who needed 0-2 vs. 3 maintenance treatments per year. The AUROC in the PPI and non-PPI group were respectively 0.576 (0.368-0.784) and 0.752 (0.606-0.899). ConclusionThe modified IAI is a fairly good predictor in non-PPI-using homozygous C282Y HH patients, to differentiate who needs 3 maintenance phlebotomies per year. Therefore, this index might help to select patients that benefit from an alternative less frequent therapy, e.g. erythrocytapheresis.
Original languageEnglish
Pages (from-to)1535-1539
JournalLiver International
Volume36
Issue number10
DOIs
Publication statusPublished - Oct 2016

Keywords

  • C282Y
  • hereditary haemochromatosis
  • maintenance treatment
  • phenotypic predictor
  • phlebotomy

Cite this